LLT1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20 results for “LLT1”

Trials

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

33 participants · First posted Jun 11, 2024

LLTS to Treat Premature Ventricular Contractions

100 participants · First posted Jun 1, 2021

A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder

First posted Aug 7, 2007

Drugs

LLT-311202

MLLT1/3 inhibitor(Dark Blue)

LLT-1 monoclonal antibodies

News

Coherus and Zumutor Launch Phase 1 Trial of NK Checkpoint Antibody ZM008 Combined with PD-1 Inhibitor LOQTORZI in Solid Tumors

Thetis Reports Positive Phase 1a Data for Novel IBD Drug TP-317, Demonstrating BLT1 Target Engagement

J-Pharma and Uniphar Advance First-in-Class LAT1 Inhibitor Nanvuranlat into Global Phase 3 Trial for Biliary Tract Cancer

Page 1 of 2